Report overview
Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
This report aims to provide a comprehensive presentation of the global market for Advanced Parenteral Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Parenteral Drug Delivery. This report contains market size and forecasts of Advanced Parenteral Drug Delivery in global, including the following market information:
Global Advanced Parenteral Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Advanced Parenteral Drug Delivery Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Advanced Parenteral Drug Delivery companies in 2022 (%)
The global Advanced Parenteral Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.
We surveyed the Advanced Parenteral Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Advanced Parenteral Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Advanced Parenteral Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
Global Advanced Parenteral Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Advanced Parenteral Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others
Global Advanced Parenteral Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Advanced Parenteral Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Advanced Parenteral Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Advanced Parenteral Drug Delivery revenues share in global market, 2022 (%)
Key companies Advanced Parenteral Drug Delivery sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Advanced Parenteral Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Outline of Major Chapters:
Chapter 1: Introduces the definition of Advanced Parenteral Drug Delivery, market overview.
Chapter 2: Global Advanced Parenteral Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Advanced Parenteral Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Advanced Parenteral Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Advanced Parenteral Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
